The FDA recently approved a 200 units/mL Humalog KwikPen, a pre-filled, rapid-acting insulin pen designed to improve glycemic control in people with type 1 and type 2 diabetes, Eli Lilly and Company ...

The Humalog Junior KwikPen, a prefilled, rapid-acting insulin pen designed to improve glycemic control in people with type 1 or type 2 diabetes, is now available for prescription in the U.S., Eli ...

Marks approval of first concentrated mealtime insulin analog in the U.S. and expands Lilly's portfolio of medicines for people with type 1 and type 2 diabetes INDIANAPOLIS, May 27, 2015 /PRNewswire/ - ...

The Humalog Junior KwikPen is lighter and shorter than other half-unit insulin pens. Eli Lilly announced the availability of Humalog Junior KwikPen (insulin lispro injection) 100 Units/mL for the ...

KwikPen, a prefilled, portable insulin pen for use with Lilly’s Humalog (insulin lispro injection [rDNA origin]) brand of insulins, is now available. KwikPens do not require refrigeration after the ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. INDIANAPOLIS, Ind.– Indianapolis-based Eli ...

(CNN) -- Pharmaceutical company Eli Lilly will sell a cheaper generic version of its rapid-acting insulin Humalog, according to a statement Monday from Chairman and CEO Dave Ricks. At 50% the price of ...